Why quality matters
World leader in the science of quality for infectious disease testing
Every day around the world, millions of people are tested for infectious diseases – including influenza, Hepatitis, HIV and COVID-19.
Keeping us all safe and connected relies on the accuracy of this testing.
NRL is a global leader in the science of quality for infectious disease testing. We support laboratories in more than 70 countries to ensure that their results are accurate, consistent and reliable.
From a new laboratory in London, to a point-of-care test in Mongolia, from a blood bank in Manila to a public laboratory in Melbourne – NRL’s mission is to create healthy communities across the globe, through supporting accurate, high-quality infectious disease testing.
Products and services
Explore what we offer
Testing
TGA licensed screening of blood and tissue donors, reference testing; and contract testing for projects
Consulting and Training
Customised and sustainable training to enhance quality of infectious disease testing through education, advocacy and mentorship.
Biobank
The SVI Biobank is a storage resource and repository for research groups, clinical trials organisations and others requiring contract storage...
Research & Development
NRL is a facility that enables new ideas and products to be brought to market
Point of Care QA
Programs designed to assure the quality of point of care testing for infectious diseases.
Quality Control Services
Comprehensive QC program providing QC samples, software and associated services to monitor the precision and accuracy of test results.
EQAS
Proficiency programs designed to assess the integrity of tests and testing processes.
Evaluations
Independent assessment of in vitro diagnostic devices (IVDs) and provision of customised validation and verification panels, data analysis and reporting
Our Story
NRL - designated as a WHO Collaborating Centre in 1985
Australia’s National (Serology) Reference Laboratory (NRL) was first established as part of the Australian Government’s HIV and AIDS strategy in 1985 and later that year was designated as a World Health Organisation (WHO) Collaborating Centre for Diagnostics and Laboratory Support for HIV and AIDS and other Blood-borne Infections.
Featured posts
The latest from NRL Quality
February 2023
Quality Control Services Updates
February 2023
1st Australasian Conference on Point of Care Testing for Infectious Diseases
January 2023
Asia Pacific Quality Summit 2023
Partnerships
We partner with global leaders in our field
